CFIC
IBB icon

City Financial Investment Company’s iShares Biotechnology ETF IBB Stock Holding History

City Financial Investment Company’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-96,000
Closed -$9.92M – 82
2017
Q2 		$9.92M Buy
+96,000
New +$9.45M 1.08% 37

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

City Financial Investment Company's IBB Position: Q3 2017 in Review

City Financial Investment Company sold out of iShares Biotechnology ETF (IBB) in Q3 2017, closing a stake of 96,000 shares — an estimated $9.92M sold.

City Financial Investment Company first reported a position in IBB in Q2 2017 and held it in 1 quarter. The position peaked at $9.92M in Q2 2017. 584 funds tracked by Wall St. Rank hold IBB as of Q3 2017.

  • City Financial Investment Company reported no remaining iShares Biotechnology ETF position as of Q3 2017 after selling out during the quarter.
  • City Financial Investment Company sold 96,000 iShares Biotechnology ETF shares in Q3 2017, an estimated $9.92M.
  • City Financial Investment Company first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 1 quarter.
  • City Financial Investment Company's iShares Biotechnology ETF position peaked at $9.92M in Q2 2017.
  • 584 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2017.

Based on City Financial Investment Company's 13F filing for Q3 2017, filed 14 Nov 2017.